TSX Venture Exchange grants conditional approval for Matador’s Change of Business (“COB”) to a hybrid “Technology / Investment” issuer, subject to the Company satisfying the TSXV’s requirements and ...

Madrigal Pharma's REZDIFFRA sees 33% Q1 2025 sales growth, strong EU progress, and promising MASH data. Read why I maintain ...